186 related articles for article (PubMed ID: 8918624)
1. Relationships between plasma ferritin and aminotransferase profile in haemodialysis patients with hepatitis C virus.
Caramelo C; Albalate M; Bermejillo T; Navas S; Ortiz A; de Sequera P; Casado S; Carreño V
Nephrol Dial Transplant; 1996 Sep; 11(9):1792-6. PubMed ID: 8918624
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of intravenous iron therapy for HCV-positive haemodialysis patients.
Kahraman S; Yilmaz R; Genctoy G; Arici M; Altun B; Erdem Y; Yasavul U; Turgan C
Nephron Clin Pract; 2005; 100(3):c78-85. PubMed ID: 15824511
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and clinical expression of HCV-genotypes in haemodialysis-patients of two geographically remote countries: Belgium and Saudi-Arabia.
Bosmans JL; Nouwen EJ; Behets G; Gorteman K; Huraib SO; Shaheen FA; Maertens G; Verpooten GA; Elseviers MM; de Broe ME
Clin Nephrol; 1997 Apr; 47(4):256-62. PubMed ID: 9128793
[TBL] [Abstract][Full Text] [Related]
4. The influence of hepatitis C infection activity on oxidative stress markers and erythropoietin requirement in hemodialysis patients.
Tutal E; Sezer S; Ibis A; Bilgic A; Ozdemir N; Aldemir D; Haberal M
Transplant Proc; 2010 Jun; 42(5):1629-36. PubMed ID: 20620489
[TBL] [Abstract][Full Text] [Related]
5. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
[TBL] [Abstract][Full Text] [Related]
6. Hepatic iron stainings in chronic hepatitis C patients with low HCV RNA levels: a predictive marker for IFN therapy.
Akiyoshi F; Sata M; Uchimura Y; Suzuki H; Tanikawa K
Am J Gastroenterol; 1997 Sep; 92(9):1463-6. PubMed ID: 9317063
[TBL] [Abstract][Full Text] [Related]
7. Liver dysfunction in patients infected with hepatitis C virus undergoing chemotherapy for hematologic malignancies.
Zuckerman E; Zuckerman T; Douer D; Qian D; Levine AM
Cancer; 1998 Sep; 83(6):1224-30. PubMed ID: 9740089
[TBL] [Abstract][Full Text] [Related]
8. Comparative study between occult hepatitis C virus infection and chronic hepatitis C.
Pardo M; López-Alcorocho JM; Rodríguez-Iñigo E; Castillo I; Carreño V
J Viral Hepat; 2007 Jan; 14(1):36-40. PubMed ID: 17212642
[TBL] [Abstract][Full Text] [Related]
9. Relationship between iron replacement and hepatic functions in hepatitis C virus-positive chronic haemodialysis patients.
Ozdemir A; Yalinbaş B; Selamet U; Eres M; Murat B; Gürsu RU; Barut Y
Nephrology (Carlton); 2005 Oct; 10(5):433-7. PubMed ID: 16221090
[TBL] [Abstract][Full Text] [Related]
10. Effect of blood letting on serum aminotransferase levels of patients with chronic hepatitis C and iron overload.
Girelli CM; Mirata C; Casiraghi A
Recenti Prog Med; 1998 May; 89(5):241-4. PubMed ID: 9676130
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of occult hepatitis B and hepatitis C virus infections in Turkish hemodialysis patients.
Yakaryilmaz F; Gurbuz OA; Guliter S; Mert A; Songur Y; Karakan T; Keles H
Ren Fail; 2006; 28(8):729-35. PubMed ID: 17162434
[TBL] [Abstract][Full Text] [Related]
12. Development of an HCV infection risk stratification algorithm for patients on chronic hemodialysis.
Herrine SK; Michael B; Ma WL; Rossi S; Dunn SR; Hyslop T
Am J Gastroenterol; 2002 Oct; 97(10):2619-22. PubMed ID: 12385449
[TBL] [Abstract][Full Text] [Related]
13. [Hepatopathy and hepatitis B virus infection in dialysis patients: cross-sectional study].
Fabrizi F; Bisegna S; Mangano S; Alongi G; Colucci P; Finazzi S; De Vecchi AF; Ponticelli C
G Ital Nefrol; 2002; 19(2):149-54. PubMed ID: 12195413
[TBL] [Abstract][Full Text] [Related]
14. Decrease in serum ferritin level in a patient with HCV hepatitis and liver hemosiderosis by interferon-alpha.
Kawada E; Shinonome S; Tamura J; Murakami H
J Med; 1994; 25(6):388-92. PubMed ID: 7769377
[TBL] [Abstract][Full Text] [Related]
15. Clinical outcome of frequent exposure to Torque Teno virus (TTV) through blood transfusion in thalassemia patients with or without hepatitis C virus (HCV) infection.
Hu YW; Al-Moslih MI; Al Ali MT; Uzicanin S; Perkins H; Yi QL; Rahimi Khameneh S; Wu J; Brown EG
J Med Virol; 2008 Feb; 80(2):365-71. PubMed ID: 18098140
[TBL] [Abstract][Full Text] [Related]
16. Gamma-glutamyltransferase activity in chronic dialysis patients and renal transplant recipients with hepatitis C virus infection.
Souza JF; Longui CA; Miorin LA; Sens YA
Transplant Proc; 2008 Jun; 40(5):1319-23. PubMed ID: 18589096
[TBL] [Abstract][Full Text] [Related]
17. [The effect of iron depletion on the response to interferon treatment in patients with chronic hepatitis C. Pilot study].
Ortiz V; Olaso V; López Viedma B; Córdoba J; Molina JM; Lainez B; Pastor M; Berenguer J
Gastroenterol Hepatol; 1999 Mar; 22(3):122-6. PubMed ID: 10228321
[TBL] [Abstract][Full Text] [Related]
18. Influence of Helicobacter pylori infection on iron accumulation in hepatitis C.
Sumida Y; Kanemasa K; Yamaoka Y; Imamura S; Katoh N; Nakashima T; Tachibana S; Mitsuyoshi H; Itoh Y; Okanoue T
Liver Int; 2006 Sep; 26(7):827-33. PubMed ID: 16911465
[TBL] [Abstract][Full Text] [Related]
19. Iron overload in patients with chronic hepatitis C virus infection: clinical and histological study.
Silva IS; Perez RM; Oliveira PV; Cantagalo MI; Dantas E; Sisti C; Figueiredo-Mendes C; Lanzoni VP; Silva A; Ferraz ML
J Gastroenterol Hepatol; 2005 Feb; 20(2):243-8. PubMed ID: 15683427
[TBL] [Abstract][Full Text] [Related]
20. Hydroxyoctadecadienoic acid as a potential biomarker for oxidative stress in patients with chronic hepatitis C.
Yoshida Y; Imai Y; Sawai Y; Saito Y; Cao J; Fukuda K; Niki E
J Gastroenterol Hepatol; 2010 Jan; 25(1):107-15. PubMed ID: 19780883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
